Medicine shortages and availability issues
Submitted by Anonymous (not verified) on 6 February 2026 - 12:47
Medicine shortages and availability issues
Drug Shortages Global Regulatory Working Group
Submitted by Anonymous (not verified) on 6 February 2026 - 12:46
Drug Shortages Global Regulatory Working Group
PSUSA/00003006/202503
Submitted by Anonymous (not verified) on 6 February 2026 - 12:22
PSUSA/00003006/202503
Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Date of authorisation: 25/06/2020, Revision: 7, Status: Authorised
Submitted by Anonymous (not verified) on 6 February 2026 - 11:00
Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Date of authorisation: 25/06/2020, Revision: 7, Status: Authorised
Agenda - Webinar on the use of platform technologies in the non-clinical and clinical domains
Submitted by Anonymous (not verified) on 6 February 2026 - 10:48
Agenda - Webinar on the use of platform technologies in the non-clinical and clinical domains
LinkedIn Live: How EMA supports innovation in medicine development, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 February 2026, 14:30 (CET) to 25 February 2026, 15:00 (CET)
Submitted by Anonymous (not verified) on 6 February 2026 - 9:17
LinkedIn Live: How EMA supports innovation in medicine development, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 February 2026, 14:30 (CET) to 25 February 2026, 15:00 (CET)
Medicines during pregnancy and breastfeeding
Submitted by Anonymous (not verified) on 6 February 2026 - 9:12
Medicines during pregnancy and breastfeeding
Human medicines European public assessment report (EPAR): Azarga, brinzolamide,timolol, Date of authorisation: 25/11/2008, Revision: 19, Status: Authorised
Submitted by Anonymous (not verified) on 6 February 2026 - 8:55
Human medicines European public assessment report (EPAR): Azarga, brinzolamide,timolol, Date of authorisation: 25/11/2008, Revision: 19, Status: Authorised
Drug Shortages Global Regulatory Working Group: Group statement published on behalf of the Working Group by EMA
Submitted by Anonymous (not verified) on 5 February 2026 - 23:00
Drug Shortages Global Regulatory Working Group: Group statement published on behalf of the Working Group by EMA
Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Date of authorisation: 12/12/2024, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 5 February 2026 - 16:30
Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Date of authorisation: 12/12/2024, Revision: 3, Status: Authorised